KLK3 and neoplasm: There were no relevant differences between the intervention (with furosemide) and control (without furosemide) scans regarding the prostate-specific antigen (PSA) levels, the prevalence of local tumor manifestation close to the bladder, renal function, or administered activity, thereby confirming the comparability of both scan conditions in this intra-individual design (Table 1).